4RG0 | Crystal structure of BTK kinase domain complexed with 2-[8-fluoro-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(4-methylpiperazin-1-yl)-2-pyridyl]amino]-6-oxo-3-pyridyl]phenyl]-1-oxo-3,4-dihydroisoquinolin-6-yl]-2-methyl-propanenitrile | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Kuglstatter, A., Wong, A. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.50 | ||||||||||||
ligand | 3P0 | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Finding the perfect spot for fluorine: Improving potency up to 40-fold during a rational fluorine scan of a Bruton's Tyrosine Kinase (BTK) inhibitor scaffold., Lou Y, Sweeney ZK, Kuglstatter A, Davis D, Goldstein DM, Han X, Hong J, Kocer B, Kondru RK, Litman R, McIntosh J, Sarma K, Suh J, Taygerly J, Owens TD, Bioorg Med Chem Lett. 2014 Nov 20. pii: S0960-894X(14)01214-1. doi:, 10.1016/j.bmcl.2014.11.030. PMID:25466710 |
Data retrieval |
View 4RG0 in 3D |
Visual 3D analysis of 4RG0 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4RG0 |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |